Table 1 Baseline patient characteristics
Characteristic | ER positive | ER negative | Total | |||
|---|---|---|---|---|---|---|
No. of patients | % | No. of patients | % | No. of patients | % | |
No. of patients | 40 | 76.9 | 12 | 23.1 | 52 | 100 |
Age, years | ||||||
Range | 42.9–82.8 | 59.4–82.5 | 42.9–82.8 | |||
Median | 70.0 | 67.7 | 69.5 | |||
FIGO stage* | 52 | 100 | ||||
I | 13 | 32.5 | 9 | 75.0 | 22 | 42.3 |
II | 6 | 15.0 | 1 | 8.3 | 7 | 13–5 |
III | 11 | 27.5 | 2 | 16.7 | 13 | 25.0 |
IV | 10 | 25.0 | 0 | 0 | 10 | 19.2 |
Grade | 52 | 100 | ||||
Well differentiated | 7 | 17.5 | 0 | 0 | 7 | 13.5 |
Mod. differentiated | 17 | 42.5 | 7 | 58.3 | 24 | 46.2 |
Poorly differentiated | 14 | 35.0 | 5 | 41.7 | 19 | 36.5 |
Not specified | 2 | 5.0 | 0 | 0 | 2 | 3.8 |
Disease status at inclusion | 52 | 100 | ||||
Relapse | 26 | 65 | 8 | 66.7 | 34 | 65.4 |
Primary metastatic disease | 14 | 35 | 4 | 33.3 | 18 | 34.6 |
Previous treatment | 52 | 100 | ||||
Surgery alone | 11 | 27.5 | 1 | 8.3 | 12 | 23.1 |
Surgery and radiation | 8 | 20.0 | 1 | 8.3 | 9 | 17.3 |
Surgery and chemotherapy | 7 | 17.5 | 3 | 25.0 | 10 | 19.2 |
Surgery, radiation and chemotherapy | 14 | 35.0 | 7 | 58.3 | 21 | 40.4 |